Faulty processing of tumor-associated antigens leads to human leukocyte antigen (HLA) and B7 costimulatory downregulation, further inhibiting the recognition of tumor cells by cytotoxic T-cells [18,19,20]. Here, CD80 is linked to neoplasm.